These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psoriasis, the liver, and the gastrointestinal tract. Gisondi P; Del Giglio M; Cozzi A; Girolomoni G Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823 [TBL] [Abstract][Full Text] [Related]
9. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Lotti T; Hercogova J; Prignano F Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis comorbidities. Gottlieb AB; Chao C; Dann F J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720 [TBL] [Abstract][Full Text] [Related]
12. [Psoriasis, a systemic disease?]. Puig-Sanz L Actas Dermosifiliogr; 2007; 98(6):396-402. PubMed ID: 17663929 [TBL] [Abstract][Full Text] [Related]
13. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL; Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603 [TBL] [Abstract][Full Text] [Related]
14. Research gaps in psoriasis: opportunities for future studies. Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079 [TBL] [Abstract][Full Text] [Related]
15. Psoriasis and cardiovascular comorbidities with emphasis in Asia. Chu TW; Tsai TF G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582 [TBL] [Abstract][Full Text] [Related]
16. Psoriasis as the marker of underlying systemic disease. Kourosh AS; Miner A; Menter A Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363 [TBL] [Abstract][Full Text] [Related]
17. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Ryan C; Kirby B Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782 [TBL] [Abstract][Full Text] [Related]
18. Psoriasis and the life cycle of persistent life effects. Garshick MK; Kimball AB Dermatol Clin; 2015 Jan; 33(1):25-39. PubMed ID: 25412781 [TBL] [Abstract][Full Text] [Related]
19. Co-morbidity in psoriasis: mechanisms and implications for treatment. Lønnberg AS; Skov L Expert Rev Clin Immunol; 2017 Jan; 13(1):27-34. PubMed ID: 27426230 [TBL] [Abstract][Full Text] [Related]
20. Comorbidities significantly impact patients' preferences for psoriasis treatments. Schmieder A; Schaarschmidt ML; Umar N; Terris DD; Goebeler M; Goerdt S; Peitsch WK J Am Acad Dermatol; 2012 Sep; 67(3):363-72. PubMed ID: 22015150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]